![5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone](https://static.cymitquimica.com/products/3D/img/XJB57393.png "Zum Vergrößern klicken")
5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
CAS: 872573-93-8
Ref. 3D-XJB57393
| 5mg | Ausgelaufen | ||
| 10mg | Ausgelaufen | ||
| 25mg | Ausgelaufen | ||
| 50mg | Ausgelaufen | ||
| 100mg | Ausgelaufen |
Produktinformation
Name:
5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
Synonyme:
- Ro-3306
- (5Z)-5-(quinolin-6-ylmethylidene)-2-(thiophen-2-ylmethylamino)-1,3-thiazol-4-one
- 5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
- (Z)-5-(quinolin-6-ylmethylene)-2-(thiophen-2-ylmethylamino)thiazol-4(5H)-one
- 2-[[(Thiophen-2-yl)methyl]amino]-5-[1-(quinolin-6-yl)meth-(Z)-ylidene]thiazol-4-one
- (5Z)-5-Quinolin-6-ylmethylene-2-[(thiophen-2-ylmethyl)-amino]-thiazol-4-one
Beschreibung:
Quizartinib is a targeted inhibitor of the protein kinase A-Raf signaling pathway and is used for the treatment of certain types of cancer. Quizartinib inhibits the polymerase chain reaction, which can lead to cell death. It also has inhibitory properties on some cancer cells by targeting her2+ breast cancer cells and inhibiting tumor growth in vivo models. Quizartinib has been shown to be effective against autoimmune diseases such as lupus erythematosus, rheumatoid arthritis, and psoriasis. This drug also exhibits pluripotency markers that are similar to those found in embryonic stem cells.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
351.45 g/mol
Formel:
C18H13N3OS2
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
